相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eph receptors: New players in Alzheimer's disease pathogenesis
Moustapha Cisse et al.
NEUROBIOLOGY OF DISEASE (2015)
Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures
Leila K. Myrick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Cassia R. Overk et al.
BIOCHEMICAL PHARMACOLOGY (2014)
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Miguel Medina et al.
BIOCHEMICAL PHARMACOLOGY (2014)
SnapShot: FMRP mRNA Targets and Diseases
Emanuela Pasciuto et al.
CELL (2014)
SnapShot: FMRP Interacting Proteins
Emanuela Pasciuto et al.
CELL (2014)
Increasing our Understanding of Human Cognition Through the Study of Fragile X Syndrome
Denise Cook et al.
DEVELOPMENTAL NEUROBIOLOGY (2014)
Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences
Joshua A. Suhl et al.
HUMAN MOLECULAR GENETICS (2014)
Decrease of ERK/MAPK Overactivation in Prefrontal Cortex Reverses Early Memory Deficit in a Mouse Model of Alzheimer's Disease
Mariana Feld et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature
Antonella Caccamo et al.
JOURNAL OF NEUROSCIENCE (2014)
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
Shichun Tu et al.
MOLECULAR NEURODEGENERATION (2014)
Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders
Emanuela Santini et al.
SCIENCE SIGNALING (2014)
Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
Hans Zempell et al.
TRENDS IN NEUROSCIENCES (2014)
CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome
Sabiha Abekhoukh et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Genetic aspects of autism spectrum disorders: insights from animal models
Swati Banerjee et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Fyn kinase inhibition as a novel therapy for Alzheimer's disease
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders
Hansen Wang
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease
Alison Hamilton et al.
MOLECULAR BRAIN (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Protein phosphatase 2A dysfunction in Alzheimer's disease
Jean-Marie Sontag et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Neuron-specific regulation of class I PI3K catalytic subunits and their dysfunction in brain disorders
Christina Gross et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
GSK-3β, a pivotal kinase in Alzheimer disease
Maria Llorens-Martin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2014)
Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
Tau protein kinases: Involvement in Alzheimer's disease
Ludovic Martin et al.
AGEING RESEARCH REVIEWS (2013)
A danse macabre': tau and Fyn in STEP with amyloid beta to facilitate induction of synaptic depression and excitotoxicity
Jannic Boehm
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
William L. Klein
JOURNAL OF ALZHEIMERS DISEASE (2013)
Alzheimer's Disease: Recent Advances and Future Perspectives
Kiren Ubhi et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
Andrea C. Paula-Lima et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Overcoming barriers and thresholds - signaling of oligomeric Aβ through the prion protein to Fyn
Hansen Wang et al.
MOLECULAR NEURODEGENERATION (2013)
What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders
C. J. Westmark
MOLECULAR PSYCHIATRY (2013)
The translation of translational control by FMRP: therapeutic targets for FXS
Jennifer C. Darnell et al.
NATURE NEUROSCIENCE (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
Emily K. Osterweil et al.
NEURON (2013)
Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
Ji Won Um et al.
NEURON (2013)
SYNAPTIC CHANGES IN ALZHEIMER'S DISEASE AND ITS MODELS
J. Pozueta et al.
NEUROSCIENCE (2013)
Reversing autism by targeting downstream mTOR signaling
Hansen Wang et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Fragile X mental retardation protein and synaptic plasticity
Michael S. Sidorov et al.
MOLECULAR BRAIN (2013)
The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Asha L. Bhakar et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 35 (2012)
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
Michael R. Santoro et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Tau-targeted treatment strategies in Alzheimer's disease
Juergen Goetz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
New perspectives on the biology of fragile X syndrome
Tao Wang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
New developments on the role of NMDA receptors in Alzheimer's disease
Roberto Malinow
CURRENT OPINION IN NEUROBIOLOGY (2012)
AMPA receptors as drug targets in neurological disease - advantages, caveats, and future outlook
Philip K. -Y. Chang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model
S. M. Goebel-Goody et al.
GENES BRAIN AND BEHAVIOR (2012)
Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome
Weixiang Guo et al.
HUMAN MOLECULAR GENETICS (2012)
Soluble A ss oligomer production and toxicity
Megan E. Larson et al.
JOURNAL OF NEUROCHEMISTRY (2012)
The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease
Megan Larson et al.
JOURNAL OF NEUROSCIENCE (2012)
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Hyejung Won et al.
NATURE (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Ji Won Um et al.
NATURE NEUROSCIENCE (2012)
Mechanisms of CaMKII action in long-term potentiation
John Lisman et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Tau as a therapeutic target in neurodegenerative disease
Diana S. Himmelstein et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Synapses and Alzheimer's Disease
Morgan Sheng et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities
Huda Y. Zoghbi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Alzheimer Disease in 2020
David M. Holtzman et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease
Colin L. Masters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory
Igor Klyubin et al.
MOLECULAR BRAIN (2012)
Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases
Hansen Wang et al.
FRONTIERS IN PHARMACOLOGY (2012)
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Peter Penzes et al.
BRAIN RESEARCH REVIEWS (2011)
What Can We Learn about Autism from Studying Fragile X Syndrome?
Dejan B. Budimirovic et al.
DEVELOPMENTAL NEUROSCIENCE (2011)
PSD-95 Is Required to Sustain the Molecular Organization of the Postsynaptic Density
Xiaobing Chen et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Pharmacological Study on Alzheimer's Drugs Targeting Calcium/Calmodulin-Dependent Protein Kinase II
Shigeki Moriguchi
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
Moustapha Cisse et al.
NATURE (2011)
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Benjamin D. Auerbach et al.
NATURE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Autism, Alzheimer disease, and fragile X APP, FMRP, and mGluR5 are molecular links
D. K. Sokol et al.
NEUROLOGY (2011)
Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
Cara J. Westmark et al.
PLOS ONE (2011)
Alzheimer's Disease
Dennis J. Selkoe
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Fragile X Syndrome and Alzheimer's Disease: Another Story About APP and β-Amyloid
J. S. Malter et al.
CURRENT ALZHEIMER RESEARCH (2010)
Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent α-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization
Hansen Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies
Eun Kyung Lee et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model
Yongfang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Keith A. Vossel et al.
SCIENCE (2010)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
Cytoskeletal Pathologies of Alzheimer Disease
James R. Bamburg et al.
CELL MOTILITY AND THE CYTOSKELETON (2009)
p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis
Qiu-Lan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors
Hansen Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
The Tyrosine Phosphatase STEP Mediates AMPA Receptor Endocytosis after Metabotropic Glutamate Receptor Stimulation
Yang Zhang et al.
JOURNAL OF NEUROSCIENCE (2008)
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Gary J. Bassell et al.
NEURON (2008)
FMRP acts as a key messenger for dopamine modulation in the forebrain
Hansen Wang et al.
NEURON (2008)
Rapid translation of Arc/Arg3.1 selectively mediates mGluR-dependent LTD through persistent increases in AMPAR endocytosis rate
Maggie W. Waung et al.
NEURON (2008)
Metabotropic Glutamate Receptors and Fragile X Mental Retardation Protein: Partners in Translational Regulation at the Synapse
Jennifer A. Ronesi et al.
SCIENCE SIGNALING (2008)
FMRP mediates mGluR5-dependent translation of amyloid precursor protein
Cara J. Westmark et al.
PLOS BIOLOGY (2007)
Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies
Michael T. Maloney et al.
MOLECULAR NEUROBIOLOGY (2007)
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration
Jian-Zhi Wang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking
Shoaib Chowdhury et al.
NEURON (2006)
Fragile X syndrome and autism at the intersection of genetic and neural networks
Matthew K. Belmonte et al.
NATURE NEUROSCIENCE (2006)
mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease
C Lafay-Chebassier et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology
RJ Griffin et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Synaptic targeting by Alzheimer's-related amyloid β oligomers
PN Lacor et al.
JOURNAL OF NEUROSCIENCE (2004)
分享论文
